Background-In ␣1-AR knockout (␣1ABKO) mice that lacked cardiac myocyte ␣1-adrenergic receptor (␣1-AR) binding, aortic constriction induced apoptosis, dilated cardiomyopathy, and death. However, it was unclear whether these effects were attributable to a lack of cardiac myocyte ␣1-ARs and whether the ␣1A, ␣1B, or both subtypes mediated protection. Therefore, we investigated ␣1A and ␣1B subtype-specific survival signaling in cultured cardiac myocytes to test for a direct protective effect of ␣1-ARs in cardiac myocytes. Methods and Results-We cultured ␣1ABKO myocytes and reconstituted ␣1-AR signaling with adenoviruses expressing ␣1-GFP fusion proteins. Myocyte death was induced by norepinephrine, doxorubicin, or H 2 O 2 and was measured by annexin V/propidium iodide staining. In ␣1ABKO myocytes, all 3 stimuli significantly increased apoptosis and necrosis. Reconstitution of the ␣1A subtype, but not the ␣1B, rescued ␣1ABKO myocytes from cell death induced by each stimulus. To address the mechanism, we examined ␣1-AR activation of extracellular signal-regulated kinase (ERK). In ␣1ABKO hearts, aortic constriction failed to activate ERK, and in ␣1ABKO myocytes, expression of a constitutively active MEK1 rescued ␣1ABKO myocytes from norepinephrine-induced death. In addition, only the ␣1A-AR activated ERK in ␣1ABKO myocytes, and expression of a dominant-negative MEK1 completely blocked ␣1A survival signaling in ␣1ABKO myocytes. Conclusions-Our results demonstrate a direct protective effect of the ␣1A subtype in cardiac myocytes and define an ␣1A-ERK signaling pathway that is required for myocyte survival. Absence of the ␣1A-ERK pathway can explain the failure to activate ERK after aortic constriction in ␣1ABKO mice and can contribute to the development of apoptosis, dilated cardiomyopathy, and death. (Circulation. 2007;115:763-772.)
A lpha-1-adrenergic receptors (␣1-ARs) are classically associated with the regulation of vascular smooth-muscle contraction, 1 but recent studies suggest important ␣1-AR functions in the heart. Clinically, ␣1-AR antagonists are used to treat hypertension and prostate enlargement with urinary symptoms. However, in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) 2 and the Veterans Administration Heart Failure Trial (V-HeFT), 3 the use of ␣1-AR antagonists worsened heart failure and increased mortality in hypertensive and heart failure patients. Because of the recent recommendation for increased use of ␣1-AR antagonist therapy in prostate hyperplasia, 4 determining the exact role of ␣1-ARs in the heart has important clinical implications.
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Using ␣1-AR knockout mice (␣1ABKO) that lacked the ␣1Aand ␣1B-AR subtypes, we demonstrated previously that ␣1-ARs are required for postnatal physiological hyper-trophy of cardiac myocytes and for adaptation to myocardial stress. 5, 6 In ␣1ABKO mice, which lack cardiac myocyte ␣1-AR binding, aortic constriction induces apoptosis, dilated cardiomyopathy, and death. These results suggest that ␣1-ARs mediate survival signaling in cardiac myocytes, which could explain the adverse outcomes after aortic constriction in ␣1ABKO mice. In addition, the adverse outcomes in ␣1ABKO mice after aortic constriction correlate with results observed in ALLHAT and V-HeFT, 2,3 cautioning against the use of ␣1-AR antagonists.
Despite these findings, several questions remain regarding ␣1-AR-mediated survival signaling. Because the ␣1ABKO was a systemic knockout, it is unclear whether the adverse outcomes after aortic constriction were caused directly by the absence of ␣1-ARs in cardiac myocytes. Furthermore, it is unclear whether the ␣1A, ␣1B, or both subtypes are required for ␣1-AR-mediated survival signaling and adaptation to myocardial stress.
To demonstrate a direct protective effect of ␣1-ARs in cardiac myocytes and to define the mechanism of protection, we examined ␣1Aand ␣1B-AR subtype-specific signaling in cultured cardiac myocytes. We also studied the role of extracellular signal-regulated kinase (ERK), a known regulator of myocyte survival, [7] [8] [9] in mediating ␣1-AR survival signaling in cardiac myocytes. In cultured ␣1ABKO cardiac myocytes, which are susceptible to death from ␤-AR stimulation and oxidative stress, 6 we reconstituted ␣1A and ␣1B subtype signaling in an attempt to reverse the susceptibility to death and, thereby, demonstrate a direct protective effect of ␣1-ARs. Our results show that reconstitution of ␣1A, but not ␣1B, subtype signaling rescued ␣1ABKO myocytes from cell death induced by norepinephrine (NE), doxorubicin, and H 2 O 2 . We also found that activation of ERK was sufficient to protect ␣1ABKO myocytes from cell death and was required for ␣1A-mediated survival signaling. Therefore, our results demonstrate a direct protective effect of the ␣1A subtype in cardiac myocytes and define an ␣1A-ERK signaling pathway that is required for myocyte survival. Absence of the ␣1A-ERK pathway can explain the failure to activate ERK after aortic constriction in ␣1ABKO mice and can contribute to the development of apoptosis, dilated cardiomyopathy, and death.
Methods

Generation of Adenoviral Constructs
To generate ␣1A-GFP and ␣1B-GFP fusion proteins, cDNAs for the human ␣1A-AR (NM000680) and ␣1B-AR (NM000679) were amplified by polymerase chain reaction with primers designed to remove the stop codon and insert Bgl II and Mlu I restriction sites 5Ј and 3Ј, respectively. The amplified ␣1A and ␣1B products were cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, Calif) and then subcloned into the Bgl II-Mlu I restriction sites in the multicloning site of the humanized pGFP 2 -N3 vector (BioSignal Packard, Montreal, Quebec, Canada), with GFP at the C-terminus. 10 -13 To generate adenoviruses expressing the ␣1A-GFP and ␣1B-GFP fusion proteins under control of the cytomegalovirus promoter, the ␣1A-AR-GFP 2 and ␣1B-AR-GFP 2 were amplified by polymerase chain reaction with primers designed to insert Pme I and Xba I restriction sites at the 5Ј and 3Ј ends, respectively. The amplified ␣1A-GFP and ␣1B-GFP products were cloned into the pCR2.1-TOPO vector (Invitrogen) and then subcloned into the Pme I-Xba I restriction sites in the Ad5CMV K-NpA vector (ViraQuest, North Liberty, Ia) under control of the cytomegalovirus promoter. The Ad5 plasmids with ␣1-AR inserts were then recombined with an adenoviral cell line. Clones positive for recombination were transfected into HEK293 cells. Viral products evident 7 to 10 days after transfection were amplified, purified through 2 rounds of CsCl gradients, and dialyzed against a 3% sucrose/phosphate buffer solution. Viral titer was determined by observing plaque formation in agarose overlay assays.
The constitutively active and dominant-negative MEK1 adenoviruses were generated as described previously. 8, 14 
Culture of Adult Mouse Cardiac Myocytes
Ventricular cardiac myocytes from adult male mice were cultured as previously described 6, 15, 16 (see the Methods section of the onlineonly Data Supplement for more detail).
Measurement of ␣1-AR Expression
␣1-AR levels and binding affinity in cultured wild type (WT) and ␣1ABKO myocytes expressing ␣1-ARs were measured by saturation binding as previously described 5 (see the Methods section of the online-only Data Supplement for more detail).
Localization of ␣1-ARs in Adult Mouse Cardiac Myocytes by Confocal Microscopy
WT or ␣1ABKO myocytes were cultured on glass coverslips. ␣1ABKO myocytes were infected with adenovirus expressing ␣1-GFPs or untagged ␣1-ARs. For uninfected WT myocytes and ␣1ABKO myocytes infected with untagged ␣1-ARs, 50 nmol/L BODIPY prazosin (Molecular Probes, Eugene, Ore) was added to the culture after 24 hours. After an additional 16 hours, myocytes were fixed with 4% paraformaldehyde and mounted on slides with fluoromount G (Electron Microscopy Sciences, Hatfield, Pa). Fluorescent images were captured by confocal microscopy using Fluoview software (Olympus BX50 confocal microscope; Olympus America Inc., Melville, NY). Images were processed for publication using Imaris software (Bitplane Scientific Solutions, St. Paul, Minn).
Measurement of ␣1-Mediated Inositol Phosphate Generation
To quantify ␣1-mediated inositol phosphate generation in both HeLa cells and ␣1ABKO myocytes expressing ␣1-ARs, we measured total inositol phosphate in response to phenylephrine treatment, using a slight modification to our previously described protocol 17 (see the Methods section of the online-only Data Supplement for more detail).
Measurement of Cell Death
Myocyte death was measured using annexin V (AnnV)/propidium iodide (PI) staining as described previously. 6, 16 For cell death assays, myocytes were infected with adenovirus and cultured for 40 hours. At 40 hours, myocytes were treated for 2 hours with NE (1 mol/L), H 2 O 2 (10 mol/L), doxorubicin (1 mol/L), or vehicle (100 mol/L ascorbic acid for NE; saline for doxorubicin). After 2 hours, AnnV-Fluos (Roche Diagnostics Corp, Indianapolis, Ind) and PI (Roche Diagnostics Corp) were added directly to the culture medium. After 10 minutes, myocytes were photographed under both phase contrast and fluorescent microscopy. For each condition, 300 to 400 myocytes were counted in randomly selected fields, and each condition was measured in duplicate. Apoptotic myocytes were defined as AnnV positive and PI negative, and necrotic myocytes were defined as AnnV and PI positive.
Measurement of MEK/ERK Signaling
ERK activity, the effects of the constitutively active MEK1 (MEK1 CA) and dominant-negative MEK1 (MEK1 D/N) mutants on ERK activity, and MEK1 levels were all measured by Western blot (phospho-and total ERK and MEK1 antibodies, Cell Signaling Technology, Beverly, Mass), as described previously. 5, 8 
Transverse Aortic Constriction
Transverse aortic constriction surgery was performed without intubation under anesthesia with isoflurane, as described previously. 5, 6 
Mice
The ␣1ABKO mice used in this study have been described previously. 5, 6 In all experiments, we used congenic C57Bl/6 male WT or knockout mice, ages 10 to 15 weeks. All protocols involving animal use were reviewed and approved by the internal animal care and use committee at the University of South Dakota.
Statistics
In all experiments, values were compared by 1-way ANOVA with Bonferonni posttest, and PϽ0.05 was considered significant. The number of experiments (n), given in each figure legend, refers to independent cultures from different hearts.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Expression and Localization of ␣1A-GFP and ␣1B-GFP Fluorescent Fusion Proteins in Cardiac Myocytes
To study ␣1-AR-mediated survival signaling, we reconstituted ␣1-AR signaling in ␣1ABKO myocytes, which lack ␣1-AR binding, using adenoviruses expressing ␣1Aor ␣1B-GFP fluorescent fusion proteins. The GFP tags allow for visualization of receptor expression and immunodetection by Western blot using a GFP antibody, because no reliable ␣1 subtype-specific antibodies are available. As a control, we also made adenoviruses expressing untagged ␣1-ARs. We measured expression levels of the ␣1-GFP and untagged ␣1 constructs in binding assays with 3 H-prazosin, and we defined a 2.5-to 4-fold level of overexpression for both the GFPtagged and untagged ␣1 constructs used in all subsequent experiments (binding assays not shown).
On expressing the ␣1Aand ␣1B-GFP fusion proteins in ␣1ABKO cardiac myocytes, we observed that the ␣1A and ␣1B-GFP both localized to the nucleus and perinucleus (Figures 1a and 1c ). To verify that this localization was not an artifact caused by the GFP tag, we also examined the Figure 1 . Localization of ␣1-AR subtypes in adult mouse cardiac myocytes. a, ␣1A-GFP; b, ␣1A-untagged with BODIPY prazosin; c, ␣1B-GFP; d, ␣1B-untagged with BODIPY prazosin; e, WT myocytes with BODIPY prazosin. Myocytes isolated from WT and ␣1ABKO hearts were plated on coverslips. ␣1ABKO myocytes were infected with adenovirus expressing ␣1-GFPs or untagged ␣1-ARs. After 24 hours, 50 nmol/L BODIPY prazosin was added to cultures of uninfected WT and ␣1ABKO myocytes expressing the untagged ␣1-ARs. After an additional 16 hours (40 hours total), myocytes were fixed in 4% paraformaldehyde, and images were captured by fluorescent confocal microscopy and merged with dualinterference contrast images to show localization of the fluorescent signal. Magnification: 600ϫ. localization of the untagged ␣1A and ␣1B subtypes in ␣1ABKO cardiac myocytes using BODIPY prazosin, a prazosin analog that fluoresces when bound to a receptor. As with the ␣1Aand ␣1B-GFP, we observed that the untagged ␣1A and -␣1B subtypes localized to the nucleus and perinucleus (Figures 1b and 1d ). Using BODIPY prazosin, we also found that ␣1-ARs in WT myocytes localized to the nucleus and perinucleus (Figure 1e ), validating our expression system.
To determine whether the GFP tag altered ␣1-mediated signaling, we measured ␣1-mediated inositol phosphate generation in HeLa cells and cardiac myocytes. In HeLa cells, the ␣1-GFP fusion proteins and untagged ␣1-ARs all increased inositol phosphate levels, and there was no difference be-tween the GFP-tagged or untagged receptors (see Figure I in the online-only Data Supplement). Maximum total inositol phosphate production was greater with the ␣1A subtype than with the ␣1B, as it was in previous studies with GFP-tagged ␣1-ARs. 13 However, we were not able to detect ␣1-mediated inositol phosphate generation in ␣1ABKO cardiac myocytes expressing our ␣1-AR constructs (endothilin-1 did increase inositol phosphate levels, data not shown), similar to previous reports in cultured WT adult mouse cardiac myocytes. 18 In summary, these results suggest that the GFP fluorescent moiety did not alter receptor localization or function, thus defining a reconstitution system using ␣1Aand ␣1B-GFP fluorescent fusion proteins. The ␣1A subtype, but not the ␣1B subtype, rescues ␣1ABKO cardiac myocytes from NE-induced cell death. a, Annexin V assay in cultured ␣1ABKO myocytes expressing the GFP-tagged or untagged ␣1 subtypes. Myocytes were cultured from WT and ␣1ABKO hearts. At 0 hours (plating), myocytes were infected with adenovirus encoding GFP-tagged or untagged ␣1A and ␣1B subtypes, or they were infected with ␤-galactosidase (␤gal) and cultured for 40 hours to allow for transgene expression. At 40 hours, myocytes were treated for 2 hours with 1 mol/L NE or vehicle (100 mol/L ascorbic acid), and cell death was assayed using annexin V/propidium iodide staining. Myocytes were photographed under phase contrast (left) and fluorescence (right) to determine the percentage of apoptotic cells (AnnV positive and PI negative) and necrotic cells (AnnV and PI positive). Magnification: 100ϫ. WT and ␣1ABKO myocytes infected with ␣1A-GFP, ␣1B-GFP, or ␤gal and treated with NE are shown. b, Cell death; c, myocyte morphology. The percentage of apoptotic (AnnV positive) and necrotic (AnnV ϩ PI positive) myocytes (b) and the number of rod-shaped and round myocytes (c) were calculated from 300 to 400 myocytes per condition and were plotted (nϭ4 to 6 independent cultures). ␤gal virus at the highest titer of virus used in all experiments did not induce cell death (see Figure II in the online-only Data Supplement).
The ␣1A Subtype, but Not the ␣1B Subtype, Rescues ␣1ABKO Cardiac Myocytes From
NE-Induced Cell Death
Previously, we demonstrated that ␣1ABKO cardiac myocytes were susceptible to death induced by NE through ␤-ARs and by oxidative stress (H 2 O 2 ). 6 Here, we reconstituted ␣1-AR signaling in ␣1ABKO cardiac myocytes to determine whether an ␣1-AR subtype-the ␣1A, ␣1B, or both-could reverse the susceptibility of ␣1ABKO myocytes to death, thus demonstrating a direct protective effect of ␣1-AR signaling in cardiac myocytes. To reconstitute ␣1-AR signaling, cultured ␣1ABKO myocytes were infected with the ␣1-AR adenoviruses (␣1A-GFP, MOI 1000; untagged ␣1A, MOI 50; ␣1B-GFP, MOI 3000; untagged ␣1B 1500) to obtain roughly equal levels of expression of each receptor (2.5-to 4-fold over basal). Myocyte death was induced with NE, which is known to cause myocyte apoptosis by activating ␤1-AR signaling. 19, 20 Myocyte death was quantified by AnnV/PI staining, where AnnV-positive and PI-negative cells were considered apoptotic, and AnnV-and PI-doublepositive cells were considered necrotic ( Figure 2 ).
As we observed previously, 6 NE (1 mol/L) did not induce cell death in WT myocytes, but in ␣1ABKO myocytes, NE significantly increased both apoptosis (PϽ0.05 versus WT NE) and necrosis (PϽ0.05 versus WT NE), which was correlated with a significant loss in rod-shaped myocyte morphology (PϽ0.05 versus WT NE) (Figure 2a through c) . Reconstitution of ␣1A subtype signaling (␣1A-GFP or untagged ␣1A) rescued ␣1ABKO myocytes from NE-induced cell death (apoptosis, necrosis, and rod shape: all PϽ0.05 versus ␣1ABKO NE), but reconstitution of ␣1B signaling (␣1B-GFP or untagged ␣1B) did not (apoptosis, necrosis, and rod shape: all PϭNS versus ␣1ABKO NE) (Figure 2a through c). We verified this result by examining NE-induced cell death in cardiac myocytes from single ␣1AKO and ␣1BKO mice, which, again, showed that the ␣1A subtype protected against NE-induced cell death (seen as increased cell death in ␣1AKO myocytes; Figure 3 ). To ensure that the higher levels of adenovirus used to express the ␣1B constructs did not induce cell death, we tested a ␤-galactosidase control virus in the same experimental protocol and found no death at the highest level of virus ( Figure II in the online-only Data Supplement). In summary, our results demonstrate that the ␣1A subtype mediates survival signaling in cardiac myocytes.
The ␣1A Subtype Rescues ␣1ABKO Cardiac Myocytes From Doxorubicin-and H 2 O 2 -Induced Cell Death
To determine whether the ␣1A subtype could protect cardiac myocytes from other known mediators of cell death, we reconstituted ␣1A subtype signaling in ␣1ABKO cardiac myocytes and measured cell death in response to doxorubicin, a chemotherapeutic agent with known cardiotoxicity, and H 2 O 2 , an inducer of oxidative stress (Figure 4 ). In ␣1ABKO myocytes, both doxorubicin (1 mol/L) and H 2 O 2 (10 mol/L) induced cell death (apoptosis: PϭNS versus ␣1ABKO control; necrosis and rod shape: PϽ0.05 versus ␣1ABKO control). Once again, reconstitution of ␣1A sub-type signaling rescued ␣1ABKO myocytes from both doxorubicin-and H 2 O 2 -induced cell death (apoptosis: PϭNS; necrosis and rod shape: PϽ0.05 versus ␣1ABKO doxorubicin or H 2 O 2 ) (Figure 4a through b) . In summary, the ␣1A subtype can prevent myocyte death induced by several different stimuli.
Activation of ERK Is Sufficient to Rescue ␣1ABKO Myocytes From NE-Induced Cell Death
Previously, we demonstrated that aortic constriction induced apoptosis, dilated cardiomyopathy, and death in ␣1ABKO mice, indicating that ␣1-AR signaling is required for myocardial adaptation to stress. 5,6 ␣1-AR-mediated activation of ERK in cardiac myocytes is a well-characterized signaling pathway, and others suggest that ␣1-AR survival signaling is mediated by ERK in neonatal rat cardiac myocytes. 21 To determine what role ERK plays in the ␣1-mediated response to myocardial stress, we measured ERK activation in ␣1ABKO mice after aortic constriction. In ␣1ABKO hearts, basal ERK activity was reduced versus WT, as demonstrated previously (Figure 5a ). 5 Furthermore, aortic constriction ac- tivated ERK in WT mice but failed to activate ERK in ␣1ABKO mice (Figure 5a ). The failure to activate ERK after aortic constriction correlates with our previous finding that aortic constriction induces apoptosis, dilated cardiomyopathy, and death in ␣1ABKO mice. 5, 6 In agreement with the reduced level of ERK activation in the ␣1ABKO heart (Figure 5a ), there is no ␣1-AR-mediated activation of ERK in ␣1ABKO myocytes. 5 To determine whether the activation of ERK could prevent NE-induced cell death in ␣1ABKO myocytes, we infected ␣1ABKO myocytes with an adenovirus expressing a constitutively active mutant of MEK1 (MEK1 CA), a kinase that directly activates ERK, and we measured NE-induced cell death ( Figure 5 ). Expression of the MEK1 CA rescued ␣1ABKO myocytes from NE-induced cell death (apoptosis, necrosis, and rod shape: all PϽ0.05 versus ␣1ABKO NE) ( Figure 5b ). In these experiments, the level of MEK1 CA used (MOI 20) produced a modest level of ERK activation (Figure 5c ). In summary, moderate activation of ERK is sufficient to protect ␣1ABKO myocytes from NE-induced cell death.
Activation of ERK Is Required for ␣1A
Subtype-Mediated Survival Signaling in Cardiac Myocytes
To determine whether ␣1A-mediated survival signaling was linked with the activation of ERK, we measured ␣1 subtypespecific activation of ERK in ␣1ABKO myocytes. Myocytes were infected with the ␣1A-GFP or ␣1B-GFP, and phenylephrine-induced activation of ERK was measured by Western blot (Figure 6 ). Reconstitution of ␣1A, but not ␣1B, subtypespecific signaling restored ␣1-AR-mediated activation of ERK (Figure 6a ). To ensure that the ␣1B-GFP construct was not defective, we measured phenylephrine-induced activation of ERK in HeLa cells as well, and we found that ␣1A-GFP and ␣1B-GFP both activated ERK (Figure 6a ). Further, we found that phorbol 12-myristate, 13-acetate activated ERK in myocytes expressing either the ␣1A or ␣1B subtype, suggesting that failure to activate ERK in myocytes expressing the ␣1B subtype was not attributable to a defect in ERK signaling (Figure 6a ). In summary, the ␣1A subtype activates ERK in cardiac myocytes, but the ␣1B does not.
To determine whether the activation of ERK was required for ␣1A-AR-mediated survival signaling, we coinfected ␣1ABKO myocytes with adenoviruses expressing the ␣1A-GFP and a dominant-negative mutant of MEK1 (MEK1 D/N), and we measured NE-induced cell death. Expression of the MEK1 D/N alone had no effect on NE-induced cell death (apoptosis, necrosis, and rod shape: all PϭNS versus ␣1ABKO NE), but it completely reversed ␣1A-AR survival signaling (apoptosis, necrosis, and rod shape: PϭNS versus ␣1ABKO NE, but PϽ0.05 versus ␣1ABKO ϩ ␣1A-GFP NE) (Figure 6b ). The coexpression of the ␣1A-GFP and MEK1 D/N adenoviruses did result in lower expression levels of the MEK1 D/N (Figure 6c ). However, the MEK1 D/N completely inhibited ␣1A-mediated activation of ERK (Figure 6d) . The MEK1 D/N also inhibited ␣1A-AR-mediated survival signaling in ␣1BKO myocytes, which express only the endogenous ␣1A subtype, confirming these results (see Figure III in the online-only Data Supplement). In summary, activation of ERK is required for ␣1A-mediated survival signaling in cardiac myocytes.
Discussion
The development of dilated cardiomyopathy and death after aortic constriction in ␣1ABKO mice demonstrates that ␣1-ARs are required for myocardial adaptation to stress. 5, 6 However, on the basis of our previous results, we could not determine whether the adverse outcomes after aortic constriction in ␣1ABKO mice were caused directly by the loss of ␣1-ARs in cardiac myocytes, nor could we determine which ␣1-AR subtype(s) was required for the adaptive response to stress. To address the limitations of our previous study, we investigated ␣1A and ␣1B subtype-specific survival signaling in cultured cardiac myocytes to test for a direct protective effect of ␣1-ARs in cardiac myocytes. Here, we found that reconstitution of ␣1A, but not ␣1B, subtype signaling rescued ␣1ABKO myocytes from cell death induced by NE, doxorubicin, and H 2 O 2 . Therefore, these results demonstrate a direct protective effect of the ␣1A subtype in cardiac myocytes. Myocytes were cultured from ␣1ABKO hearts. At 0 hours (plating), myocytes were infected with adenovirus encoding ␣1A-GFP or ␤gal, cultured for 40 hours, and then treated for 2 hours with 1 mol/L doxorubicin, 10 mol/L H 2 0 2 , or vehicle. Cell death was assayed as described in Figure 2 (nϭ3 independent cultures).
In addition to defining a direct protective role for the ␣1A subtype in cardiac myocytes, we also identified an ␣1A-ERK signaling pathway that is critical for ␣1-AR-mediated survival signaling. In previous studies, inhibition of ERK increased apoptosis in both cultured cardiac myocytes and isolated perfused hearts subjected to ischemia. 7 Further, cardiac-specific transgenic overexpression of MEK1 inhibited apoptosis induced by ischemia/reperfusion. 8 In ERK2 knockout mice, ischemia/reperfusion increased apoptosis and myocardial injury. 9 These findings clearly demonstrate that ERK signaling is protective in the heart. Here, we found that aortic constriction failed to activate ERK in ␣1ABKO mice and that activation of ERK, using a constitutively active mutant of MEK1, was sufficient to protect cultured ␣1ABKO cardiac myocytes from NE-induced death. We also found that the ␣1A, but not the ␣1B, mediated ERK activation in ␣1ABKO cardiac myocytes, and inhibition of ERK, with a dominant-negative mutant of MEK1, completely blocked ␣1A survival signaling. Therefore, our findings are consistent with a protective role for an ␣1A-ERK pathway. Further, the lack of ␣1A-ERK survival signaling could explain the failure to activate ERK after aortic constriction in ␣1ABKO mice, and this might ultimately explain the development of apoptosis, dilated cardiomyopathy, and death.
An unexpected result was that ␣1-ARs localized to the nucleus and perinucleus in WT cardiac myocytes and ␣1ABKO myocytes expressing ␣1-GFP fluorescent fusion proteins. However, we cannot exclude the possibility that inactive, unoccupied receptor resides at the plasma membrane. Classical models of GPCR function suggest that GPCRs are expressed on the membrane and only internalize after desensitization. However, a previous report found that ␣1-ARs are expressed in myocyte nuclei. 22 Moreover, both ␤1-ARs and endothelin receptors localize to the nuclear membrane and activate nuclear signaling in the cardiac myocytes. 23, 24 In cultured adult mouse myocytes, we failed to Figure 5 . Activation of ERK is sufficient to rescue ␣1ABKO myocytes from NE-induced cell death. a, Activation of ERK in ␣1ABKO mice after aortic constriction. Transverse aortic constriction surgery (TAC) was performed in WT and ␣1ABKO mice (3 mice per group, labeled 1, 2, and 3). After 2 weeks, whole-heart homogenates were prepared, and ERK activity was measured by Western blot for phospho-and total ERK in sham and TAC-operated mice. b, Cell death and myocyte morphology in cultured ␣1ABKO myocytes expressing MEK1 CA. Myocytes were cultured from ␣1ABKO hearts. At 0 hours (plating), myocytes were infected with adenovirus encoding ␣1A-GFP, MEK1 CA, or ␤gal, cultured for 40 hours, and then treated for 2 hours with 1 mol/L NE or vehicle (100 mol/L ascorbic acid). Cell death was assayed as described in Figure 2 (nϭ4) . c, Activation of ERK in cultured ␣1ABKO myocytes expressing MEK1 CA. ␣1ABKO myocytes were cultured and infected with MEK1 CA. After 40 hours, myocyte whole-cell homogenates were prepared, and ERK activity was measured by Western blot for phospho-ERK (pERK) and total ERK(tERK).
observe ␣1-mediated inositol phosphate generation; this was consistent with previous studies. 18 However, we are currently testing whether we can detect inositol phosphate generation in nuclei isolated from cultured adult mouse myocytes.
The neurohormonal hypothesis of heart failure states that the basis for pathological ventricular remodeling in heart failure is increased sympathetic activity and NE release.
Clinically, this provided the basis for the successful use of ␤-blockers to treat heart failure. 25 Interestingly, ␤1-ARs induce myocyte apoptosis, 19, 20 and transgenic overexpression of ␤1-ARs induces progressive heart failure with increased cardiac myocyte apoptosis. 26, 27 Our current and previous results demonstrate that the ␣1A subtype prevents cell death and seems to offset ␤1-AR proapoptotic signaling. 5,6 Because Figure 6 . Activation of ERK is required for ␣1A subtype-mediated survival signaling in myocytes. a, Activation of ERK in cultured ␣1ABKO myocytes and HeLa cells expressing the ␣1A or ␣1B subtype. Myocytes cultured from ␣1ABKO hearts and HeLa cells were infected with adenovirus encoding ␣1A-GFP, ␣1B-GFP, or ␤Gal. At 40 hours, cells were treated for 15 minutes with phenylephrine (PE, 20 mol/L), phorbol 12-myristate, 13-actetate (P, 100 nmol/L), or vehicle (C, control). Whole-cell homogenates were prepared, and ERK activity was measured by Western blot for phospho-and total ERK. b, Cell death and myocyte morphology in cultured ␣1ABKO myocytes expressing the ␣1A subtype with or without MEK1 D/N. Myocytes were cultured from ␣1ABKO hearts. At 0 hours (plating), myocytes were infected with adenovirus encoding ␣1A-GFP with or without MEK1 D/N, or they were infected with ␤gal and cultured for 40 hours, then treated for 2 hours with 1 mol/L NE or vehicle (100 mol/L ascorbic acid). Cell death was assayed as described in Figure  2 (nϭ4) . c, Expression of ␣1A-GFP and MEK1 D/N in ␣1ABKO myocytes. Myocytes were cultured and infected with ␣1A-GFP and/or MEK1 D/N. After 40 hours, myocytes were harvested, whole-cell homogenates were prepared, and ␣1A-GFP and MEK1 D/N expression were measured by Western blots for GFP or MEK1. Bands for ␣1A-GFP (left blot) and MEK1 D/N (right blot) are indicated by hash marks on the left side of each blot, and molecular weights are shown on the far right. d, Activation of ERK in cultured ␣1ABKO myocytes expressing the ␣1A-AR with or without MEK1 D/N. Myocytes were cultured and infected with ␣1A-GFP and/or MEK1 D/N. After 40 hours, myocytes were treated for 15 minutes with phenylephrine (PE, 20 mol/L), phorbol 12-myristate, 13-actetate (P, 100 nmol/L), or vehicle (C, control). Whole-cell homogenates were prepared, and ERK activity was measured by Western blot for phospho-and total ERK. low levels of apoptosis are sufficient to induce heart failure in mice 28 (and quite possibly also in humans 29, 30 ), our results demonstrate a direct protective function of the ␣1A subtype in cardiac myocytes that might prevent or delay the onset of heart failure. Our results might also explain the adverse effects of ␣1-antagonists in ALLHAT and V-HeFT. 2, 3 In addition, these findings support a reconsideration of the neurohormonal hypothesis of heart failure and the idea that blocking all adrenergic receptor activation is beneficial in the treatment of heart failure.
In summary, our results demonstrate a direct protective effect of the ␣1A subtype in cardiac myocytes and define an ␣1A-ERK signaling pathway that is required for myocyte survival. Our results also imply that systemic factors do not explain the maladaptive phenotype of the ␣1ABKO after aortic constriction. Instead, absence of the ␣1A-ERK pathway in cardiac myocytes can explain the failure to activate ERK after aortic constriction in ␣1ABKO mice and can contribute to the development of apoptosis, dilated cardiomyopathy, and death. 6 Finally, these data suggest a plausible mechanism for the adverse effects of ␣1-antagonists in ALLHAT and V-HeFT. 2, 3 These data also raise the possibility that ␣1A subtype-selective agonist therapy might be cardioprotective, as also suggested by some recent studies with ␣1A-transgenic mice. 31, 32 
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